On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

While our understanding of Alzheimer’s disease is far from complete, the latest therapies, and others in more than 100 ...

Long-term benzodiazepine use in older adults disrupts sleep patterns, leading to lighter sleep and potential cognitive ...

Alzheimer’s disease has proved to be a tricky target, and researchers and drug developers have been pursuing effective ...

Discover investment opportunities in Rezolute, Inc. as new drug ersodetug advances in phase 3 HI trials, with catalysts ...

For example, St. John’s wort can interfere with how medicines are metabolized in the liver, while ginseng and ephedra may ...

Bicara Therapeutics Inc.’s ficera shows strong results in HPV-negative HNSCC trials. But is BCAX stock worth buying now?

The open-angle glaucoma market is projected to grow steadily, driven by the rising global prevalence of glaucoma due to aging populations and increasing awareness of early diagnosis. Additionally, the ...

Medicenna Therapeutics Corp. ('Medicenna” or the 'Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage cancer immunotherapy company focused on the development of Superkines, announced today that Dr.

Higher activity of PGC-1α enables brown fat cells in females to achieve thermogenic activity and energy expenditure compared ...

Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.

Higher activity of PGC-1α enables brown fat cells in females to thermogenic activity and energy expenditure compared to males ...